title: HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha.
authors: University Hospital, Department of Internal Medicine, Haematology, Oncology, Immunology and Rheumatology, Otfried-Müller-Str 10, D-72076 Tübingen, Germany. ina.koetter@med.uni-tuebingen.de
authors: I
authors: I
authors: Kötter
authors: C
authors: C
authors: Aepinus
authors: F
authors: F
authors: Graepler
authors: V
authors: V
authors: Gärtner
authors: A K
authors: AK
authors: Eckstein
authors: N
authors: N
authors: Stübiger
authors: B
authors: B
authors: Kaskas
authors: M
authors: M
authors: Zierhut
authors: B
authors: B
authors: Bültmann
authors: R
authors: R
authors: Kandolf
authors: L
authors: L
authors: Kanz
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy*; D019288:Herpesvirus 8, Human / Q000302:isolation & purification*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy / Q000276:immunology*; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000276:immunology*
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins